Treatment of steroid dependant cases of recurrent lepra reaction with a combination of thalidomide and clofazimine.
22 Adult Male Lepromatous patients suffering from recurrent lepra reaction have been allotted to either a regimen of combined treatment with Clofazimine and Thalidomide alone. The initial dosage of either of the drugs was 300 mg daily administered in divided doses of 100 mg three times a day. The preliminary assessment of the ongoing study, indicates that the combined treatment controls the reactional state more rapidly than monotherapy with Thalidomide alone. Results of treatment as regards relief of neuritis and arthritis are particularly gratifying. Four month.ases relapsed into reactional status from 2 days to 15 days. 5 cases on the combined therapy relapsed from one to three months. Three other cases required six months and three cases 8 months treatment before clofazimine could be withdrawn. It would appear that a maintenance therapy of 6 months with flofazimine would be necessary for maintaining the control of reactional episodes while employing this combined therapy.
D000328:Adult; D002991:Clofazimine / Q000008:administration & dosage* / Q000627:therapeutic use; D003622:Dapsone / Q000627:therapeutic use; D004359:Drug Therapy, Combination; D006801:Humans; D007918:Leprosy / Q000188:drug therapy*; D008297:Male; D012008:Recurrence; D013256:Steroids / Q000627:therapeutic use; D013792:Thalidomide / Q000008:administration & dosage* / Q000627:therapeutic use; D013997:Time Factors
D013256:Steroids; D013792:Thalidomide; D003622:Dapsone; D002991:Clofazimine